We interview and study famous financial billionaires, including Warren Buffett, Ray Dalio, and Howard Marks, and teach you what we learn and how you can apply their investment strategies in the stock market. We Study Billionaires is the largest stock investing podcast show in the world with 180,000,000+ downloads and is hosted by Stig Brodersen, Preston Pysh, William Green, Clay Finck, and Kyle Grieve. This podcast also includes the Richer Wiser Happier series hosted by best-selling author W ...
…
continue reading
Trade & Industrial Policy Strategies Podcasts
Columbia Energy Exchange features in-depth conversations with the world’s top energy and climate leaders from government, business, academia and civil society. The program explores today’s most pressing opportunities and challenges across energy sources, financial markets, geopolitics and climate change as well as their implications for both the U.S. and the world.
…
continue reading
Bloomberg's Joe Weisenthal and Tracy Alloway explore the most interesting topics in finance, markets and economics. Join the conversation every Monday and Thursday.
…
continue reading
America’s Commercial Real Estate Show™ is the nation’s leading show on commercial real estate related topics. Leading economists, analysts and market leaders including show host Michael Bull share valuable market intel, forecasts and strategies. New shows every week since 2010.
…
continue reading
Trade & Industrial Policy Strategies (TIPS) is an independent, non-profit, economic research institution established in 1996 to support economic policy development. Dive into a wealth of economic research and industrial policy insights from our researchers. Listen to the body of research today and empower yourself with knowledge on technological change, the just transition, industry data, trade trends, and much more.
…
continue reading
1
Old Capital Real Estate Investing Podcast with Michael Becker & Paul Peebles
Michael Becker & Paul Peebles
30
534
The Old Capital Real Estate Investing Podcast is aimed at Multifamily Real Estate Investors both new and seasoned. Hosts Michael Becker and Paul Peebles deliver no-hype education from an experienced commercial banker’s perspective. You will gain valuable insights from in-depth interviews with real life investors who are actively acquiring and operating apartment complexes in today’s environment. You will discover how they are identifying, financing and operating multifamily properties, as we ...
…
continue reading
In this environment of uncertainty, it's more important than ever for investors to think outside the box. Welcome to The Outthinking Investor, an award-winning podcast from PGIM that examines past events, present-day opportunities, and future possibilities across global capital markets. In Season 5, hosted by Toby Ricketts, experts from PGIM and the investment world bring unique perspectives as we explore a fast-changing landscape of investment opportunities and risks. Join us as we take a d ...
…
continue reading
A weekly discussion of current affairs in China with journalists, writers, academics, policymakers, business people and anyone with something compelling to say about the country that's reshaping the world. Hosted by Kaiser Kuo.
…
continue reading
Welcome to No Strings Attached, a podcast designed to inform, inspire, and occasionally entertain anyone connected to the world of window coverings. Whether you’re a trade professional, an interior designer, a curious homeowner, or someone who simply enjoys honest stories about business and life and the pursuit of the American Dream, this show has something for you. The voice behind the mic? That’s me—Roger Magalhaes, founder of Shades In Place & Trading Up Consulting and a proud veteran of ...
…
continue reading
This podcast series focuses on insightful one-to-one conversations between Frank Vitagliano, CEO of the Global Technology Distribution Council (GTDC) and respected thought leaders from the IT community. From executives of the world’s leading tech distributors and tech vendors to esteemed analysts, researchers and other astute professionals, guests share their unique perspectives on trends and activities in the channel in a non-promotional and unbiased format.
…
continue reading
Welcome to Supply Chain of Thought—the podcast that unpacks the complex world of global trade, logistics, and sourcing with expert insights and real-world strategies. Join us as we break down the biggest trends, challenges, and opportunities shaping international supply chains. From policy shifts to procurement strategies, we're giving you practical takeaways to navigate the ever-changing world of supply chain management.
…
continue reading
The African Programme on Rethinking Development Economics (APORDE) is a high high-level training programme in development economics targeting policy-makers, researchers, academics and civil society representatives from Africa and other developing countries. The programme has been running since 2007 and is a joint initiative between the South African Department of Trade, Industry and Competition (the dtic) and Trade and Industrial Policy Strategies (TIPS). As part of APORDE’s agenda of influe ...
…
continue reading
1
The Future of Supply Chain: a Dynamo Ventures Podcast
The Future of Supply Chain: a Dynamo Podcast
25301
On each episode of the Future of Supply Chain, we sit down with a different entrepreneur, investor, or industry veteran to discuss their story, views on the industry, and how we can collectively build the future of supply chain together.
…
continue reading
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
1
The Creating Wealth Show Blogcast
Jason Hartman with Ben Carson, Noam Chomsky, Robert Kiyosaki, John McAfee, Brian Tracy, John Sculley, Thomas Sowell, Pat Buchanan, Jim Rogers, John Gray, Harry Dent, Bill Ayers, Steve Forbes, Daniel Pink, Todd Akin, Meredith Whitney, Denis Waitley
1279
This is a short professional reading, audio blog or blogcast from the JasonHartman.com blog. You'll learn how to survive and thrive in today’s economy as business and real estate investment guru, Jason Hartman shows you innovative ways to "game the system" relating to the American economic mess, Wall Street scams, mortgage meltdown, inflation induced debt destruction, deflation and monetary policy. Jason shares his no-hype investment strategies for REO's / foreclosures, auctions, lease optio ...
…
continue reading
Green New Perspective is a podcast exploring technologies shaping the future. With 25,000 monthly listeners and 75,000 YouTube views, it features industry leaders sharing breakthrough advancements, growth strategies, and insights driving global change. The Green New Perspective podcast is sponsored by New Perspective, a growth-focused digital marketing agency with over 20 years of experience helping innovative B2B tech companies scale. If you or your organization is looking to grow, visit ww ...
…
continue reading
1
Seeking the Next DeepSeek: the Chinese Generative AI Algorithm Registry, with Kendra Schaefer
1:03:57
1:03:57
Play later
Play later
Lists
Like
Liked
1:03:57
This week on Sinica, I speak with Kendra Schaefer, the partner at Trivium China who heads their tech practice. She recently published a fascinating paper looking at the Cyberspace Administration of China's comprehensive database of generative AI tools released in China, and she shares the insights and big takeaways from her research on that databas…
…
continue reading
1
Freight Fraud Exposed: Strategies for Survival in the Digital Age with Michael Grace of Highway
29:25
29:25
Play later
Play later
Lists
Like
Liked
29:25
Highlights from their conversation include: Overview of Highway and Michael's Background in Freight (1:35) Rise of Freight Fraud (2:29) Types of Fraud Encountered (5:52) Fraudulent Carrier Tactics (8:11) Highway's Carrier Vetting Process (10:23) Impact of Freight Fraud (11:53) Highway's Identity Engine (16:57) Comparison with Other Tools (19:09) Qu…
…
continue reading
1
Pharma and Biotech Daily: Roche and Jazz's Promising Lung Cancer Combo, Trump's Tariffs Impact, and BioAgilytix's Drug Production Capabilities at BIO International
1:11
1:11
Play later
Play later
Lists
Like
Liked
1:11
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche and Jazz Pharmaceuticals presented data at ASCO showing that their drug combination improved survival in a phase III lung cancer trial, with analysts noting a strong treatment effect. Jazz has filed for FDA approva…
…
continue reading
1
BTC237: Bitcoin & the Insurance Industry w/ Garrett Johnston (Bitcoin Podcast)
1:04:54
1:04:54
Play later
Play later
Lists
Like
Liked
1:04:54
Garrett Johnston shares why Bitcoin—not crypto—should be the foundation for insurance innovation. We explore regulatory friction, risk evolution, and strategic adoption for carriers and corporates. IN THIS EPISODE YOU’LL LEARN: 00:00 - Intro 04:57 - How digital asset risk profiles evolve as companies scale 16:09 - The case for Bitcoin in insurance …
…
continue reading
1
Obstacles to Energy Consensus in Congress
46:37
46:37
Play later
Play later
Lists
Like
Liked
46:37
In today's polarized political landscape, energy policy has become increasingly partisan. States rich in both fossil fuels and renewable resources must confront growing electricity demand and aging infrastructure. Meanwhile, the Trump administration is pushing to defund critical energy projects under the Inflation Reduction Act while also opening n…
…
continue reading
1
Pharma and Biotech Daily: Key Updates in the World of Pharmaceuticals and Biotechnology
1:33
1:33
Play later
Play later
Lists
Like
Liked
1:33
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Regeneron's shares have dropped due to the failure of their dupixent follow-up drug, while Sanofi has acquired Blueprint for $9.5 billion to expand their rare disease portfolio. Bristol Myers Squibb is collaborating with …
…
continue reading
1
Why It's So Hard for Apple to Move Production from China to India
46:02
46:02
Play later
Play later
Lists
Like
Liked
46:02
President Trump wants Apple to make iPhones in America. The company itself has talked about — and to some extent already has been — moving more of its production to other countries, like India. But in reality, Apple remains deeply, deeply enmeshed in the Chinese supply chain. In fact, the rise of Apple, and the iPhone specifically, is the ultimate …
…
continue reading
1
Pharma and Biotech Daily: Catching up on the Latest in the Industry
0:47
0:47
Play later
Play later
Lists
Like
Liked
0:47
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The Summit's bispecific drug missed the survival endpoint in a global Phase III trial, but analysts remain optimistic about its potential to appeal to both Eastern and Western patient populations. Sanofi and Regeneron saw…
…
continue reading
1
TIP726: From Obscurity to Opportunity: Jon Cukierwar’s Investment Edge
1:25:39
1:25:39
Play later
Play later
Lists
Like
Liked
1:25:39
On today’s episode, Kyle Grieve chats with Jon Cukierwar about his unique global investing approach focused on undiscovered companies. They delve into Jon’s high-conviction strategy, his in-depth on-the-ground research process, and how he uncovers overlooked opportunities by combining valuation, quality, and growth. IN THIS EPISODE YOU’LL LEARN: 00…
…
continue reading
What is a currency? This turns out to be one of those questions we just kind of skip over because we don't have clear answers to it (and because economists often like to skip over these foundational things). This special episode of the Odd Lots podcast was recorded as part of Princeton University's “How to Write the Biography of a Currency” event, …
…
continue reading
1
Krishna Memani on Wall Street's Very Expensive "Free Lunch"
39:20
39:20
Play later
Play later
Lists
Like
Liked
39:20
We're told over and over again that the one "free lunch" in investing is diversification, and that you can improve your returns over time simply by investing in a wider range of assets. This is textbook modern finance. And yet over the past several years this hasn't been the case. An investor would have done great (with the occasional hiccups) just…
…
continue reading
1
Pharma and Biotech Daily: Top News in Gene Therapy, Vaccine Contracts, and Industry Updates
0:51
0:51
Play later
Play later
Lists
Like
Liked
0:51
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Intellia reported an adverse event in its gene therapy trial, causing its stock to drop, adding to existing safety concerns in gene therapy. Analysts downplayed the event, but patient deaths in other trials have raised…
…
continue reading
1
TIP725: First Principles of Valuation w/ Tim Koller
1:02:51
1:02:51
Play later
Play later
Lists
Like
Liked
1:02:51
On today’s episode, Clay is joined by Tim Koller to discuss all things valuation. Tim is the lead author of Valuation: Measuring and Managing the Value of Companies which is the #1 best-selling guide to business valuation. This book—now in its eighth edition—has sold more than one million copies, and is used as a textbook at top business schools su…
…
continue reading
1
Bonus Ep: Rubio's Visa Revocations, with Jeremy Goldkorn [Explicit]
49:42
49:42
Play later
Play later
Lists
Like
Liked
49:42
Jeremy Goldkorn joins for this largely unedited throwback to the early, sweary days of the show. We talk about the announcement made on Wednesday, 28 May 2025, on the "aggressive" revocation of Chinese student visas for students with Party "connections" or who study "critical fields." You've been warned! See Privacy Policy at https://art19.com/priv…
…
continue reading
1
Michael Cembalest on Why AI Is the Stock Market Bet of the Century
58:52
58:52
Play later
Play later
Lists
Like
Liked
58:52
Michael Cembalest has been an investment analyst for almost 40 years and his research notes have drawn a cult following on Wall Street. He's known for going super deep into a wide range of topics, like energy and healthcare. And lately he's been writing a lot about AI, with a particular interest in figuring out whether all the investment in data ce…
…
continue reading
1
Pharma and Biotech Daily: Insider Trading, R&D Spending, and Acquisitions in the World of Pharmaceuticals
1:59
1:59
Play later
Play later
Lists
Like
Liked
1:59
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former Chinook board member, Rouzbeh Haghighat, has been indicted for insider trading related to Novartis' $3.2 billion acquisition of the company. Despite this scandal, pharma R&D spending increased in 2024, climbing 1.5…
…
continue reading
1
Self Storage Sector & REITs with Tyson Huebner
20:16
20:16
Play later
Play later
Lists
Like
Liked
20:16
Tyson Huebner, Director of Institutional Research at Yardi Matrix, joins Michael Bull to discuss the self-storage sector and REITs. Topics include the current trends in self-storage performance, including the impact of recent market fluctuations and rental rate strategies. Tyson shares insights on occupancy rates, cap rate trends, and the evolving …
…
continue reading
1
Re-Air: The Impact of Emerging Technologies on Traditional European Freight Brokerage Business Models with David Nothacker of sennder
35:28
35:28
Play later
Play later
Lists
Like
Liked
35:28
Highlights from their conversation include: David’s background and journey in co-founding sennder (0:41) European Freight Market Dynamics (2:39) The State of the European Freight Industry (4:47) Diversification and Business Strategy (6:14) Influence of Market Dynamics on Strategy (8:40) Outlook for 2024 and Managed Transportation Capability (10:47)…
…
continue reading
1
Pharma and Biotech Daily: Navigating the Complexities of mRNA Technology and Gene Therapies
1:42
1:42
Play later
Play later
Lists
Like
Liked
1:42
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.A patient death has led to the halt of Rocket's gene therapy trial for Danon disease, due to complications from an acute systemic infection. This incident highlights the unpredictable nature of gene therapies and may pose…
…
continue reading
1
Building a Successful AI Strategy: A Summit EMEA Expert Panel Discussion
41:18
41:18
Play later
Play later
Lists
Like
Liked
41:18
Organizations are increasingly dependent on technologies that streamline and automate operations, and AI allows channel partners to deliver in both areas for their clients. That is just one of the benefits of artificial intelligence that are discussed with a panel of industry experts in this episode of Beyond Distribution, which was recorded live a…
…
continue reading
1
BTC236: Stablecoin GENIUS Act & Bitcoin Policy Update w/ Matt Pines (Bitcoin Podcast)
1:02:22
1:02:22
Play later
Play later
Lists
Like
Liked
1:02:22
Preston and Matthew discuss the upcoming Bitcoin Policy Summit, explore strategic financial maneuvers involving Bitcoin, dissect stablecoin impacts, and examine shifting global crypto dynamics. IN THIS EPISODE YOU’LL LEARN: 00:00 - Intro 01:20 - Challenges facing the Federal Reserve’s independence 13:21 - Insights into Elon's policy influence and f…
…
continue reading
President Trump's recent visit to the Gulf region marked a dramatic shift from the previous administration’s Middle East diplomacy. In his visit to Saudi Arabia, the UAE, and Qatar, Trump focused on securing significant investment commitments and commercial partnerships to support the region's AI and other ambitions. The trip showcased Trump’s tran…
…
continue reading
1
Pharma and Biotech Daily: Navigating Turbulent Times in the Biopharma Industry
0:50
0:50
Play later
Play later
Lists
Like
Liked
0:50
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The biopharma industry is currently facing challenges such as tariff threats and regulatory upheaval. The market has been described as 'moribund' with the need for companies to survive in these tough times. Recent top st…
…
continue reading
1
Why Asset Allocators Love Multi-Strategy Hedge Funds
49:43
49:43
Play later
Play later
Lists
Like
Liked
49:43
Multi-strategy hedge funds have been having a moment with big asset allocators pouring billions of dollars into names like Millennium and Citadel. And given all the growth, multi-strat funds have also been battling each other for talent. But why, exactly, do big investors seem to love multi-strats so much? What actually makes a multi-strat good to …
…
continue reading
1
Pharma and Biotech Daily: Your Daily Dose of What Matters in the Industry
1:07
1:07
Play later
Play later
Lists
Like
Liked
1:07
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.A court has halted the Trump administration's plans to reduce and lay off employees in government agencies, citing a lack of authority. Meanwhile, a report called "Make American Healthy Again" criticizes pharmaceutical lobb…
…
continue reading
1
TIP724: Key Insights From Coca-Cola's Golden Era
1:08:45
1:08:45
Play later
Play later
Lists
Like
Liked
1:08:45
On today’s episode, Kyle Grieve chats about one of the most iconic businesses in history—Coca-Cola—and explores its enduring competitive advantages, its remarkable turnaround under CEO Roberto Goizueta, and what Warren Buffett saw that made it one of Berkshire Hathaway’s most legendary investments. Kyle unpacks why Coke’s brand power, global distri…
…
continue reading
Send Us Your Questions & Feedback! 🔊 Episode Summary: After a brief hiatus, Roger Magalhães returns to the mic with renewed energy, sharper focus, and a lot to share. In this comeback episode, he pulls back the curtain on what’s been happening behind the scenes — from shifting business gears in Tampa, rethinking work-life balance, to launching fres…
…
continue reading
1
Zohran Mamdani, the Socialist Who Could Be NYC's New Mayor
46:58
46:58
Play later
Play later
Lists
Like
Liked
46:58
We're just a month away from the hotly-contested Democratic primary for New York City Mayor. And one of the candidates -- Queens assemblyman Zohran Mamdani -- is running on a somewhat unusual platform. Endorsed by the Democratic Socialists of America, he's proposing rent freezes, universal childcare, higher taxes on corporations and the wealthy, fr…
…
continue reading
1
Pharma and Biotech Daily: Stay Informed on the Latest Industry Updates
0:58
0:58
Play later
Play later
Lists
Like
Liked
0:58
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sanofi has acquired Vigil for $470 million upfront, sparking interest in the Alzheimer's target Trem2 following previous failures. The FDA is encouraging states to import drugs from Canada to alleviate drug shortages. In o…
…
continue reading
1
TIP723: The Art of Buying Growth Companies for Value Prices w/ Jim Zimmerman and Abigail Zimmerman
1:17:29
1:17:29
Play later
Play later
Lists
Like
Liked
1:17:29
On today’s episode, Kyle Grieve chats with James and Abigail Zimmerman about the strength of growing and sustainable cash flowing businesses; the importance of strong balance sheets; how they navigate their circle of competence, and the steps they take to expand it; why simplicity is so important in an age of complexity, how they use cash as a boos…
…
continue reading
1
Ukraine, China, and the Emerging Geopolitics of Resource Security
1:28:57
1:28:57
Play later
Play later
Lists
Like
Liked
1:28:57
A bonus episode this week. On May 22, I moderated a panel organized by Vita Golod and the UNC Center for Slavic, Eurasian, and East European Studies. The focus was on the U.S.-Ukraine Mineral Security Partnership, and it features Ivan Us, Chief Consultant at the Center for Foreign Policy at the National Institute for Strategic Studies; Jim Mullinax…
…
continue reading
1
They Outsmarted Global Trade: The Excel Dryer’s Strategy
29:39
29:39
Play later
Play later
Lists
Like
Liked
29:39
How do you innovate in an overlooked industry? William Gagnon, VP & COO at Excel Dryer, shares how they built a global brand with the XLERATOR hand dryer—staying U.S.-made, sustainable, and ahead of the curve. We talk product innovation, tariff resilience, and educating tough markets. 📚 Get FREE B2B Marketing Trends for 2025 Report ━━━━━━━━━━━━━━━━…
…
continue reading
1
Why Interest Rates Are Shooting Up All Around the World
43:20
43:20
Play later
Play later
Lists
Like
Liked
43:20
This week the big story in markets is the selloff in bonds. Yields on benchmark 10-year US Treasuries jumped 20 basis points from last Friday’s low, while the 30-year rate is back above 5%. Meanwhile, 30-year Japanese government bonds clocked their highest yield since records began in 1999. And rates on UK gilts, German bunds, and Australian bonds …
…
continue reading
1
Survival Strategies and Strategic Partnerships: The Latest in Pharma and Biotech
1:45
1:45
Play later
Play later
Lists
Like
Liked
1:45
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Moderna has withdrawn its application for a combination flu and COVID-19 vaccine after discussions with the FDA. The vaccine had shown efficacy in eliciting antibodies, but the company decided to pull the application. In …
…
continue reading
1
Senior Housing Market 2025 with Ernie Anaya
25:28
25:28
Play later
Play later
Lists
Like
Liked
25:28
Ernie Anaya, President of the Senior Housing Group at Bull Realty, joins Michael Bull, CCIM to discuss senior housing performance and strategies for investors, developers, and operators. Bull Realty - Customized Asset & Occupancy Solutions: https://www.bullrealty.com/ Commercial Agent Success Strategies - The ultimate commercial broker training res…
…
continue reading
1
House of Huawei: Eva Dou of the Washington Post on Her New "Secret History" of Huawei
1:08:40
1:08:40
Play later
Play later
Lists
Like
Liked
1:08:40
This week on Sinica, I chat with Eva Dou, technology reporter for the Washington Post, about her terrific new book about Huawei. From its prehistory to its fight for its life under tremendous U.S. pressure, she tells its story in a way that's both deeply engaging and very evenhanded. 04:53 – Meng Wanzhou’s case and its impact on media interest in H…
…
continue reading
1
Drones, Deals & Disruption: Manna's Bobby Healy on Food Delivery’s Next Era
35:01
35:01
Play later
Play later
Lists
Like
Liked
35:01
Highlights from their conversation include: Manna's Mission (1:23) Customer Adoption Rates (4:56) Regulatory Environment (7:54) Scaling Operations (8:38) Regulatory Advice (13:01) Community Engagement Challenges (16:38) Importance of Local Communication (20:59) Impact of Scale on Delivery Economics (24:05) Doordash's Offensive Strategy (27:06) Chal…
…
continue reading
1
Pharma and Biotech Daily: Pfizer's $6 Billion Bet, CRISPR Baby Success, and Bio-Rad's Antibody Discovery Platform
1:10
1:10
Play later
Play later
Lists
Like
Liked
1:10
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer has made a $6 billion bet on acquiring 3SBio's PD-1/VEGF antibody, despite being a late entrant to the space. This deal comes after Pfizer's partnership with Summit Therapeutics, causing some confusion about the p…
…
continue reading
1
BTC235: Jack Mallers on XXI (21) and Strike Borrowing and Lending (Bitcoin Podcast)
1:10:15
1:10:15
Play later
Play later
Lists
Like
Liked
1:10:15
Explore the launch of Twenty One Capital, its strategic ties with Tether, SoftBank, and Cantor Fitzgerald, and how it compares to MicroStrategy or ETFs. Plus, Strike’s bold leap into secure Bitcoin lending. IN THIS EPISODE YOU’LL LEARN: 00:00 - Intro15:29 - How Twenty One Capital was formed and why now is the right time for a Bitcoin-native public …
…
continue reading
We often associate energy poverty with developing nations, but the reality is that tens of millions of Americans struggle to pay their monthly energy bills. Oftentimes, they forgo heating or cooling their homes in order to pay rent or buy food. And ultimately, they risk losing access to energy altogether, through utility shutoffs. For families livi…
…
continue reading
